Here Are Some Essential Facts About Intuitive Surgical (ISRG)

Intuitive Surgical logged a 1.6% change during today's afternoon session, and is now trading at a price of $330.2 per share. On average, analysts give it a target price of $314.79.

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The large-cap company is based in the United States.

What to Consider if You Are Thinking of Buying Intuitive Surgical:

  • Intuitive Surgical has moved 61.0% over the last year.

  • ISRG has a forward P/E ratio of 51.4 based on its EPS guidance of 6.42.

  • Over the last 4 years, earnings per share (EPS) have been growing at a compounded average rate of -1.4%.

  • The company has a price to earnings growth (PEG) ratio of 3.75.

  • Its Price to Book (P/B) ratio is 10.31

Intuitive Surgical Has Consistent Free Cash Flow

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cashflow ($ k) YoY Growth (%)
2022-12-31 1,490,800 -532,400 958,400 -44.79
2021-12-31 2,089,400 -353,500 1,735,900 51.83
2020-12-31 1,484,800 -341,500 1,143,300 -2.5
2019-12-31 1,598,200 -425,600 1,172,600 n/a

Intuitive Surgical's free cash flows are on average positive at $1.25 Billion, and display significant resilience over the last 4 years since their coefficient of variability is only 26.8% with a -4.9% growth rate.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS